Halozyme Therapeutics
HALO
#2478
Rank
HK$45.21 B
Marketcap
HK$355.39
Share price
-15.40%
Change (1 day)
15.26%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024HK$17.9 M-29.77%
2023HK$25.5 M-15.59%
2022HK$30.2 M38.39%
2021HK$21.82 M-6.23%
2020HK$23.27 M-44.23%
2019HK$41.74 M591.9%
2018HK$6.03 M-64.48%
2017HK$16.98 M-5.65%
2016HK$17.99 M-13.05%
2015HK$20.7 M-7.81%
2014HK$22.45 M140.61%
2013HK$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
HK$0.65 MHK$13.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$41.73 MHK$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.62 MHK$53.13 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$50.21 MHK$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.64 MHK$71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
HK$70.18 MHK$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA